What is the long-term trend for Bausch Health Companies's research and development expense?

Over 4 years (2021 to 2025), Bausch Health Companies's research and development expense has grown at a 7.8% compound annual growth rate (CAGR), from $465M to $629M.

Bausch Health Companies BHC Research and development expense

Research and development expense at other companies

Johnson & JohnsonJNJ

$3.53B+9.4%

Bausch + LombBLCO

——

AbbVieABBV

——

OrganonOGN

——

Neurocrine BiosciencesNBIX

——

ViatrisVTRS

——

Segments

By segment

See full

Bausch + Lomb$45M+60.7%

Salix$19M+11.8%

Solta Medical$8M+60.0%

International$6M0.0%

Diversified$3M0.0%

Other financials

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

See full

Market cap$1.86B-15.9%

Profitability

See full

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch Health Companies's research and development expense?: Bausch Health Companies (BHC) reported research and development expense of $163M in Q1 2026.
How has Bausch Health Companies's research and development expense changed year-over-year?: Bausch Health Companies's research and development expense increased by 14.0% year-over-year, from $143M to $163M.
What is the long-term trend for Bausch Health Companies's research and development expense?: Over 4 years (2021 to 2025), Bausch Health Companies's research and development expense has grown at a 7.8% compound annual growth rate (CAGR), from $465M to $629M.